162 related articles for article (PubMed ID: 26634247)
21. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids.
Wan H; Oridate N; Lotan D; Hong WK; Lotan R
Cancer Res; 1999 Jul; 59(14):3518-26. PubMed ID: 10416619
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of chromosome 3p deletion on the expression of the putative tumor suppressor RAR beta and on retinoid resistance in human squamous carcinoma cells.
Zou CP; Youssef EM; Zou CC; Carey TE; Lotan R
Oncogene; 2001 Oct; 20(47):6820-7. PubMed ID: 11687961
[TBL] [Abstract][Full Text] [Related]
24. CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid.
Liu RZ; Garcia E; Glubrecht DD; Poon HY; Mackey JR; Godbout R
Mol Cancer; 2015 Jul; 14():129. PubMed ID: 26142905
[TBL] [Abstract][Full Text] [Related]
25. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
[TBL] [Abstract][Full Text] [Related]
26. Higher potency of the synthetic retinoid MX3350-1 compared to the natural all-trans-retinoic acid in modulation of cell cycle and induction of apoptosis in head and neck squamous carcinoma cells.
Chun KH; Lotan R
Cell Death Differ; 2006 Oct; 13(10):1830-2. PubMed ID: 16601752
[No Abstract] [Full Text] [Related]
27. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
Roberts TJ; Colevas AD; Hara W; Holsinger FC; Oakley-Girvan I; Divi V
Cancer; 2016 May; 122(9):1388-97. PubMed ID: 26969807
[TBL] [Abstract][Full Text] [Related]
28. Biological and clinical implications of retinoic acid-responsive genes in human hepatocellular carcinoma cells.
Kanki K; Akechi Y; Ueda C; Tsuchiya H; Shimizu H; Ishijima N; Toriguchi K; Hatano E; Endo K; Hirooka Y; Shiota G
J Hepatol; 2013 Nov; 59(5):1037-44. PubMed ID: 23831118
[TBL] [Abstract][Full Text] [Related]
29. Enhanced turnover of all-trans-retinoic acid and increased formation of polar metabolites in head and neck squamous cell carcinoma lines compared with normal oral keratinocytes.
Klaassen I; Brakenhoff RH; Smeets SJ; Snow GB; Braakhuis BJ
Clin Cancer Res; 2001 Apr; 7(4):1017-25. PubMed ID: 11309353
[TBL] [Abstract][Full Text] [Related]
30. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
Fischer CA; Zlobec I; Green E; Probst S; Storck C; Lugli A; Tornillo L; Wolfensberger M; Terracciano LM
Int J Cancer; 2010 Mar; 126(5):1256-62. PubMed ID: 19697324
[TBL] [Abstract][Full Text] [Related]
31. Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma.
Castillo-González AC; Nieto-Cerón S; Pelegrín-Hernández JP; Montenegro MF; Noguera JA; López-Moreno MF; Rodríguez-López JN; Vidal CJ; Hellín-Meseguer D; Cabezas-Herrera J
BMC Cancer; 2015 May; 15():385. PubMed ID: 25956553
[TBL] [Abstract][Full Text] [Related]
32. Isolation of head and neck squamous carcinoma cancer stem-like cells in a syngeneic mouse model and analysis of hypoxia effect.
Duarte S; Loubat A; Momier D; Topi M; Faneca H; Pedroso de Lima MC; Carle GF; Pierrefite-Carle V
Oncol Rep; 2012 Sep; 28(3):1057-62. PubMed ID: 22825753
[TBL] [Abstract][Full Text] [Related]
33. The induction of P450-mediated oxidation of all-trans retinoic acid by retinoids in head and neck squamous cell carcinoma cell lines.
Kim SY; Han IS; Yu HK; Lee HR; Chung JW; Choi JH; Kim SH; Byun Y; Carey TE; Lee KS
Metabolism; 1998 Aug; 47(8):955-8. PubMed ID: 9711991
[TBL] [Abstract][Full Text] [Related]
34. New sources of retinoic acid synthesis revealed by live imaging of an Aldh1a2-GFP reporter fusion protein throughout zebrafish development.
Pittlik S; Begemann G
Dev Dyn; 2012 Jul; 241(7):1205-16. PubMed ID: 22592974
[TBL] [Abstract][Full Text] [Related]
35. Association between phosphorylated AMP-activated protein kinase and acetyl-CoA carboxylase expression and outcome in patients with squamous cell carcinoma of the head and neck.
Su YW; Lin YH; Pai MH; Lo AC; Lee YC; Fang IC; Lin J; Hsieh RK; Chang YF; Chen CL
PLoS One; 2014; 9(4):e96183. PubMed ID: 24769813
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell carcinoma of the head and neck.
Klein Nulent TJ; Van Diest PJ; van der Groep P; Leusink FK; Kruitwagen CL; Koole R; Van Cann EM
Br J Oral Maxillofac Surg; 2013 Oct; 51(7):604-9. PubMed ID: 23601830
[TBL] [Abstract][Full Text] [Related]
37. Valproic acid: growth inhibition of head and neck cancer by induction of terminal differentiation and senescence.
Gan CP; Hamid S; Hor SY; Zain RB; Ismail SM; Wan Mustafa WM; Teo SH; Saunders N; Cheong SC
Head Neck; 2012 Mar; 34(3):344-53. PubMed ID: 21438066
[TBL] [Abstract][Full Text] [Related]
38. TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer.
Wu X; Cao W; Wang X; Zhang J; Lv Z; Qin X; Wu Y; Chen W
Mol Cancer; 2013 Dec; 12(1):151. PubMed ID: 24289313
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of growth and squamous-cell differentiation markers in cultured human head and neck squamous carcinoma cells by beta-all-trans retinoic acid.
Jetten AM; Kim JS; Sacks PG; Rearick JI; Lotan D; Hong WK; Lotan R
Int J Cancer; 1990 Jan; 45(1):195-202. PubMed ID: 1967595
[TBL] [Abstract][Full Text] [Related]
40. Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells.
Zhu WY; Jones CS; Amin S; Matsukuma K; Haque M; Vuligonda V; Chandraratna RA; De Luca LM
Cancer Res; 1999 Jan; 59(1):85-90. PubMed ID: 9892191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
